MedTrace Logo

The Effect of a Breakfast Meal Containing Oat β-glucan on Food Intake at a Subsequent Meal in Normal-weight and Overweight Subjects

NCT03490851 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2019-12-02

No results posted yet for this study

Summary

The objectives of this study are to determine, in normal-weight and overweight subjects the effect of: Primary: oatmeal containing 4 g oat β-glucan on food intake at a subsequent meal compared to Cream of Rice cereal. Secondary: (i) oatmeal containing 2 g oat β-glucan on food intake at a subsequent meal compared to Cream of Rice cereal; and (ii) oatmeal containing 2g, 4g and 4g low MW oat beta-glucan on subjective appetite ratings, gastric emptying, postprandial responses of glucose, insulin, ghrelin and PYY levels compared to those elicited by Cream of Rice cereal. In addition, the relationship between amount, MW and viscosity of OBG and the primary and secondary objectives will be determined.

Conditions

  • Satiety

Interventions

OTHER

Oatmeal + OatWell28CF Int 1

Intervention involves consumption of one cereal in the beginning of each visit of the crossover sequence.

OTHER

Oatmeal + OatWell28CF Int 2

Intervention involves consumption of one cereal in the beginning of each visit of the crossover sequence.

OTHER

Oatmeal + OatWell28CF Int 3

Intervention involves consumption of one cereal in the beginning of each visit of the crossover sequence.

OTHER

Cream of Rice

Intervention involves consumption of one cereal in the beginning of each visit of the crossover sequence.

Sponsors & Collaborators

  • DSM Nutritional Products, Inc.

    collaborator INDUSTRY

  • PepsiCo Global R&D

    lead INDUSTRY

Principal Investigators

  • Thomas Wolever, MD · Glycemic Index Laboratories, Inc

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-07
Primary Completion
2017-11-28
Completion
2017-11-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03490851 on ClinicalTrials.gov